A

Armata Pharmaceuticals Inc
AMEX:ARMP

Watchlist Manager
Armata Pharmaceuticals Inc
AMEX:ARMP
Watchlist
Price: 1.59 USD 3.92%
Market Cap: 57.5m USD

Intrinsic Value

ARMP's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ARMP stock under the Base Case scenario is 1.98 USD. Compared to the current market price of 1.59 USD, Armata Pharmaceuticals Inc is Undervalued by 20%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARMP Intrinsic Value
1.98 USD
Undervaluation 20%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Armata Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ARMP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ARMP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Armata Pharmaceuticals Inc
AMEX:ARMP
US
Biotechnology
Market Cap
57.5m USD
IPO
May 20, 1994
US
Biotechnology
Market Cap
57.5m USD
IPO
May 20, 1994
Price
$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Armata Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Armata Pharmaceuticals Inc

Current Assets 11.3m
Cash & Short-Term Investments 9.3m
Receivables 744k
Other Current Assets 1.3m
Non-Current Assets 75.1m
PP&E 54.9m
Intangibles 13.7m
Other Non-Current Assets 6.5m
Efficiency

Free Cash Flow Analysis
Armata Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Armata Pharmaceuticals Inc

Revenue
5.2m USD
Operating Expenses
-47.6m USD
Operating Income
-42.4m USD
Other Expenses
23.5m USD
Net Income
-18.9m USD
Fundamental Scores

ARMP Profitability Score
Profitability Due Diligence

Armata Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
ROE is Increasing
ROIC is Increasing
Positive 3-Years Revenue Growth
29/100
Profitability
Score

Armata Pharmaceuticals Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ARMP Solvency Score
Solvency Due Diligence

Armata Pharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
34/100
Solvency
Score

Armata Pharmaceuticals Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARMP Price Targets Summary
Armata Pharmaceuticals Inc

Wall Street analysts forecast ARMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARMP is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Lowest
Price Target
7.07 USD
345% Upside
Average
Price Target
7.14 USD
349% Upside
Highest
Price Target
7.35 USD
362% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Armata Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARMP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ARMP Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARMP stock?

The intrinsic value of one ARMP stock under the Base Case scenario is 1.98 USD.

Is ARMP stock undervalued or overvalued?

Compared to the current market price of 1.59 USD, Armata Pharmaceuticals Inc is Undervalued by 20%.

Back to Top